Somalogic stock.

Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...

Somalogic stock. Things To Know About Somalogic stock.

If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Quest Diagnostics has raised a total of. $750M. in funding over 1 round. This was a Post-IPO Debt round raised on Oct 30, 2023. Quest Diagnostics is registered under the ticker NYSE:DGX . Quest Diagnostics has made 3 investments. Their most recent investment was on Nov 20, 2023, when Universal Diagnostics raised. €64.2M.Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and ...

SomaLogic Inc.'s (SLGC) stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with ...In the process, SomaLogic will receive up to $651 million in cash from CMLS II’s IPO earnings and common stock purchases from a handful of investors, bringing its total amount of cash available ...

Somalogic Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Stocks whose Next Earnings Date falls within …

Aug 12, 2021 · The ownership percentages with respect to the post-combination and PIPE Investment are based on aggregate Merger Consideration of 125,000,000 shares of CMLS II Class A Common Stock (assuming no cash elections will be made by SomaLogic stockholders) and assume 116,013,417 shares will be issued at Closing to current holders of issued and ... SomaLogic: A Look into Hedge Fund Activity and Stock Ratings SomaLogic Inc. (NASDAQ:SLGC) has recently caught the attention of large investors, as Mitchell Mcleod Pugh & Williams Inc. and Raymond James & Associates both bought new positions in the company worth $30,000 and $33,000 respectively.Headline. SomaLogic Inc Class A. morningstar.com - November 22 at 6:40 PM. With 54% ownership of the shares, SomaLogic, Inc. (NASDAQ:SLGC) is heavily dominated by institutional owners. finance.yahoo.com - November 22 at 1:39 PM. SomaLogic, Inc. (NASDAQ:SLGC) Q3 2023 Earnings Call Transcript. …Oct 4, 2023 · SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools shareholders will own 43% of the ... Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today reported financial results for the third quarter …

Raising full year 2023 revenue guidance to $82 million to $85 million. BOULDER, Colo., Nov. 08, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today reported recent business highlights and financial results for the quarter ended September 30, 2023. “We’re pleased to report another quarter of solid …

Get the latest Somalogic Inc (SLGC) stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's financial performance, balance sheet, cash flow, and earnings per share for the fiscal Q2 2023 ended 6/30/23.

SomaLogic's stock was trading at $0.40 on January 1st, 2023. Since then, SLGCW shares have decreased by 65.0% and is now trading at $0.14. View the best growth stocks for 2023 here. This page (NASDAQ:SLGCW) was last updated on 10/12/2023 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free.Standard BioTools Inc. and SomaLogic Inc. have agreed to merge in an all-stock deal to combine suppliers of tools to the medical research and drug development industry. The deal gives the combined ...SLGC Sales Forecast. Next quarter’s sales forecast for SLGC is $21.05M with a range of $20.60M to $21.60M. The previous quarter’s sales results were $22.05M. SLGC beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 45.92% of the time in the same period.Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...Get the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend yield, market cap, beta, PE ratio, EPS and more.Raising full year 2023 revenue guidance to $82 million to $85 million. BOULDER, Colo., Nov. 08, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today reported recent business highlights and financial results for the quarter ended September 30, 2023. “We’re pleased to report another quarter of solid …

Mar 28, 2023 · SomaLogic projects revenue for the full year 2023 to range from $80 million to $84 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Tuesday, March 28, 2023 to discuss its fourth quarter 2022 financial results. Those interested in listening to the conference call should register online here ... SomaLogic Inc.’s SLGC, +10.78% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to …Oct 4, 2023 · Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year Outlook SomaLogic ( CMII) ( CMIIU) is currently the leader in next generation proteomics with a suite of products already on the market giving SomaLogic first mover advantage in next gen platforms. The ...Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...The investor owns 7.01% of the outstanding SomaLogic stock. The first SomaLogic trade was made in Q3 2021. Since then Cathie Wood bought shares six more times and sold shares on two occasions. The investor's estimated purchase price is $49.9 Million, resulting in a loss of 28%. Avg closing price. Price range. Increased shares by 2.3% (+289 …

Public companies currently own 5.5% of SomaLogic stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged.Ark Investment Management has been accumulating the stock recently and owns 3.1% of SomaLogic stock. The current market cap of the company is $2.03B and the enterprise value is $1.8B. Over a long ...

Filing of certain prospectuses and communications in connection with business combination transactions. Other. 0001104659-23-106611.pdf. 0001104659-23-106611.rtf. 0001104659-23-106611.xls. View HTML. Oct 04, 2023. 425. Filing of certain prospectuses and communications in connection with business combination transactions.SomaLogic shareholders will receive 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock owned. Upon the close of the deal, Standard BioTools shareholders will ...Endpoints News — SomaLogic, co-founder of acquired company battle in court over unvested stock News • Jun 29, 2023 Benzinga — Analyst Ratings for ConcentrixIf you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...SomaLogic, Inc. (NasdaqGM:SLGC) entered into a definitive agreement to acquire to acquire Standard BioTools Inc. (NasdaqGS:LAB) from Viking Global Opportunities Illiquid Investments Sub-Master LP and Viking Global Opportunities Drawdown (Aggregator) LP, managed by Viking Global Investors LP and others for approximately $570 million in a reverse merger transaction on October 4, 2023.The average price point forecasted by analysts for SomaLogic Inc (SLGC) is $4.70, which is $2.18 above the current market price. The public float for SLGC is 152.97M, and currently, short sellers hold a 5.10% ratio of that floaft. The average trading volume of SLGC on November 15, 2023 was 1.50M shares. Top 5 AI Stocks to Buy for 2023.

Private companies and public companies own 3.6% and 5.5% of SomaLogic stock respectively. Understanding the ownership structure of a company is crucial in assessing its potential future performance. However, it is important to consider various other factors when making investment decisions. Conducting thorough research and analysis, …

Nov 7, 2023 · Corporate: On October 4, 2023, the Company announced an all-stock merger with SomaLogic, which is expected to build a diversified leader in life sciences tools. The Company expects to close the ...

--SomaLogic, Inc., a leader in proteomics technology, today reported financial results for the quarter ended March 31, 2023. ... Common stock, $0.0001 par value; ...Nov 22, 2023 · Why SomaLogic Stock Dived by 10% on Wednesday msn.com - October 4 at 6:56 PM: Shareholder Alert: Ademi LLP investigates whether SomaLogic, Inc. has obtained a Fair Price in its transaction with Standard BioTools benzinga.com - October 4 at 1:56 PM: SLGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SomaLogic, Inc. SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in ...Research SomaLogic's (Nasdaq:SLGC) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Research SomaLogic's (Nasdaq:SLGC) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard …SomaLogic last released its earnings results on November 8th, 2023. The reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.05. The firm had revenue of $22.05 million for the quarter, compared to analysts' expectations of $20.45 million. SomaLogic has generated ($0.69) earnings per share over the last year ...common stock and SomaLogic preferred stock held in SomaLogic’s treasury or owned by the Company, Merger Sub or SomaLogic immediately prior to the Effective Time (each an “E x c l ude d Share”), will be cancelled and no consideration will be paid or payable with respect thereto and (ii) each share of SomaLogic stock, other thanFollowing the transaction, the combined company was renamed SomaLogic, Inc., and its Class A common stock and warrants will begin trading on the Nasdaq Global Market (“Nasdaq”) on September 2 ...Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years. SomaLogic stock is a proteomics play that claims to have a significant first-mover advantage. They're also looking to enable their tech on Illumina ...SomaLogic saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 7,810,000 shares, a drop of 1.1% from the previous total of 7,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment.7 hours ago · SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – and SomaLogic, Inc. (Nasdaq: SLGC), a leader in data-driven proteomics technology, today announced that the companies have set a date for their respective Special Meetings of ... All earnings call transcripts on SomaLogic, Inc. (SLGC) stock. Read or listen to the conference call. Download the investor presentation - earnings call ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.

SomaLogic, Inc. (76X0.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock SomaLogic, Inc. | Börse Stuttgart: 76X0 | Börse StuttgartStocks United States SLGC Overview Stock Screener Earnings Calendar Sectors Nasdaq | SLGC U.S.: Nasdaq SomaLogic Inc. Watch list NEW Set a price target alert Open Last Updated: Nov 15, 2023... Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …Instagram:https://instagram. toast revenuecost of bar of golddental insurance plans in ohioamzn candlestick SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ... how can i invest in chat gptablv stock Shares of SomaLogic (SLGC-0.35%) ... The healthcare stock is down more than 9% this year. The move was considerable considering the stock was trading at $1.99 a share on Monday, just a penny above ... sofi bank stock Standard BioTools ( NASDAQ: LAB) said it will combine in an all stock merger with SomaLogic ( NASDAQ: SLGC) The combined company will have a pro forma equity value of over $1B as per LAB's closing ...Oct 11, 2023 · "Based on stock prices, people don't seem to like this deal," said Kyle Mikson, an analyst with Canaccord Genuity who covers SomaLogic. "People knew Standard BioTools was going to buy something and SomaLogic makes a kind of sense, but I'm sure SomaLogic investors wanted a better premium and Standard BioTools investors wanted a more proven asset ...